Cargando…
Noninvasive Assessment of an Engineered Bioactive Graft in Myocardial Infarction: Impact on Cardiac Function and Scar Healing
Cardiac tissue engineering, which combines cells and biomaterials, is promising for limiting the sequelae of myocardial infarction (MI). We assessed myocardial function and scar evolution after implanting an engineered bioactive impedance graft (EBIG) in a swine MI model. The EBIG comprises a scaffo...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442807/ https://www.ncbi.nlm.nih.gov/pubmed/28191775 http://dx.doi.org/10.5966/sctm.2016-0063 |
_version_ | 1783238472966864896 |
---|---|
author | Gálvez‐Montón, Carolina Bragós, Ramon Soler‐Botija, Carolina Díaz‐Güemes, Idoia Prat‐Vidal, Cristina Crisóstomo, Verónica Sánchez‐Margallo, Francisco M. Llucià‐Valldeperas, Aida Bogónez‐Franco, Paco Perea‐Gil, Isaac Roura, Santiago Bayes‐Genis, Antoni |
author_facet | Gálvez‐Montón, Carolina Bragós, Ramon Soler‐Botija, Carolina Díaz‐Güemes, Idoia Prat‐Vidal, Cristina Crisóstomo, Verónica Sánchez‐Margallo, Francisco M. Llucià‐Valldeperas, Aida Bogónez‐Franco, Paco Perea‐Gil, Isaac Roura, Santiago Bayes‐Genis, Antoni |
author_sort | Gálvez‐Montón, Carolina |
collection | PubMed |
description | Cardiac tissue engineering, which combines cells and biomaterials, is promising for limiting the sequelae of myocardial infarction (MI). We assessed myocardial function and scar evolution after implanting an engineered bioactive impedance graft (EBIG) in a swine MI model. The EBIG comprises a scaffold of decellularized human pericardium, green fluorescent protein‐labeled porcine adipose tissue‐derived progenitor cells (pATPCs), and a customized‐design electrical impedance spectroscopy (EIS) monitoring system. Cardiac function was evaluated noninvasively by using magnetic resonance imaging (MRI). Scar healing was evaluated by using the EIS system within the implanted graft. Additionally, infarct size, fibrosis, and inflammation were explored by histopathology. Upon sacrifice 1 month after the intervention, MRI detected a significant improvement in left ventricular ejection fraction (7.5% ± 4.9% vs. 1.4% ± 3.7%; p = .038) and stroke volume (11.5 ± 5.9 ml vs. 3 ± 4.5 ml; p = .019) in EBIG‐treated animals. Noninvasive EIS data analysis showed differences in both impedance magnitude ratio (−0.02 ± 0.04 per day vs. −0.48 ± 0.07 per day; p = .002) and phase angle slope (−0.18° ± 0.24° per day vs. −3.52° ± 0.84° per day; p = .004) in EBIG compared with control animals. Moreover, in EBIG‐treated animals, the infarct size was 48% smaller (3.4% ± 0.6% vs. 6.5% ± 1%; p = .015), less inflammation was found by means of CD25(+) lymphocytes (0.65 ± 0.12 vs. 1.26 ± 0.2; p = .006), and a lower collagen I/III ratio was detected (0.49 ± 0.06 vs. 1.66 ± 0.5; p = .019). An EBIG composed of acellular pericardium refilled with pATPCs significantly reduced infarct size and improved cardiac function in a preclinical model of MI. Noninvasive EIS monitoring was useful for tracking differential scar healing in EBIG‐treated animals, which was confirmed by less inflammation and altered collagen deposit. Stem Cells Translational Medicine 2017;6:647–655 |
format | Online Article Text |
id | pubmed-5442807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54428072017-06-15 Noninvasive Assessment of an Engineered Bioactive Graft in Myocardial Infarction: Impact on Cardiac Function and Scar Healing Gálvez‐Montón, Carolina Bragós, Ramon Soler‐Botija, Carolina Díaz‐Güemes, Idoia Prat‐Vidal, Cristina Crisóstomo, Verónica Sánchez‐Margallo, Francisco M. Llucià‐Valldeperas, Aida Bogónez‐Franco, Paco Perea‐Gil, Isaac Roura, Santiago Bayes‐Genis, Antoni Stem Cells Transl Med Translational Research Articles and Reviews Cardiac tissue engineering, which combines cells and biomaterials, is promising for limiting the sequelae of myocardial infarction (MI). We assessed myocardial function and scar evolution after implanting an engineered bioactive impedance graft (EBIG) in a swine MI model. The EBIG comprises a scaffold of decellularized human pericardium, green fluorescent protein‐labeled porcine adipose tissue‐derived progenitor cells (pATPCs), and a customized‐design electrical impedance spectroscopy (EIS) monitoring system. Cardiac function was evaluated noninvasively by using magnetic resonance imaging (MRI). Scar healing was evaluated by using the EIS system within the implanted graft. Additionally, infarct size, fibrosis, and inflammation were explored by histopathology. Upon sacrifice 1 month after the intervention, MRI detected a significant improvement in left ventricular ejection fraction (7.5% ± 4.9% vs. 1.4% ± 3.7%; p = .038) and stroke volume (11.5 ± 5.9 ml vs. 3 ± 4.5 ml; p = .019) in EBIG‐treated animals. Noninvasive EIS data analysis showed differences in both impedance magnitude ratio (−0.02 ± 0.04 per day vs. −0.48 ± 0.07 per day; p = .002) and phase angle slope (−0.18° ± 0.24° per day vs. −3.52° ± 0.84° per day; p = .004) in EBIG compared with control animals. Moreover, in EBIG‐treated animals, the infarct size was 48% smaller (3.4% ± 0.6% vs. 6.5% ± 1%; p = .015), less inflammation was found by means of CD25(+) lymphocytes (0.65 ± 0.12 vs. 1.26 ± 0.2; p = .006), and a lower collagen I/III ratio was detected (0.49 ± 0.06 vs. 1.66 ± 0.5; p = .019). An EBIG composed of acellular pericardium refilled with pATPCs significantly reduced infarct size and improved cardiac function in a preclinical model of MI. Noninvasive EIS monitoring was useful for tracking differential scar healing in EBIG‐treated animals, which was confirmed by less inflammation and altered collagen deposit. Stem Cells Translational Medicine 2017;6:647–655 John Wiley and Sons Inc. 2016-09-02 2017-02 /pmc/articles/PMC5442807/ /pubmed/28191775 http://dx.doi.org/10.5966/sctm.2016-0063 Text en © 2016 The Authors Stem Cells Translational Medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Translational Research Articles and Reviews Gálvez‐Montón, Carolina Bragós, Ramon Soler‐Botija, Carolina Díaz‐Güemes, Idoia Prat‐Vidal, Cristina Crisóstomo, Verónica Sánchez‐Margallo, Francisco M. Llucià‐Valldeperas, Aida Bogónez‐Franco, Paco Perea‐Gil, Isaac Roura, Santiago Bayes‐Genis, Antoni Noninvasive Assessment of an Engineered Bioactive Graft in Myocardial Infarction: Impact on Cardiac Function and Scar Healing |
title | Noninvasive Assessment of an Engineered Bioactive Graft in Myocardial Infarction: Impact on Cardiac Function and Scar Healing |
title_full | Noninvasive Assessment of an Engineered Bioactive Graft in Myocardial Infarction: Impact on Cardiac Function and Scar Healing |
title_fullStr | Noninvasive Assessment of an Engineered Bioactive Graft in Myocardial Infarction: Impact on Cardiac Function and Scar Healing |
title_full_unstemmed | Noninvasive Assessment of an Engineered Bioactive Graft in Myocardial Infarction: Impact on Cardiac Function and Scar Healing |
title_short | Noninvasive Assessment of an Engineered Bioactive Graft in Myocardial Infarction: Impact on Cardiac Function and Scar Healing |
title_sort | noninvasive assessment of an engineered bioactive graft in myocardial infarction: impact on cardiac function and scar healing |
topic | Translational Research Articles and Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442807/ https://www.ncbi.nlm.nih.gov/pubmed/28191775 http://dx.doi.org/10.5966/sctm.2016-0063 |
work_keys_str_mv | AT galvezmontoncarolina noninvasiveassessmentofanengineeredbioactivegraftinmyocardialinfarctionimpactoncardiacfunctionandscarhealing AT bragosramon noninvasiveassessmentofanengineeredbioactivegraftinmyocardialinfarctionimpactoncardiacfunctionandscarhealing AT solerbotijacarolina noninvasiveassessmentofanengineeredbioactivegraftinmyocardialinfarctionimpactoncardiacfunctionandscarhealing AT diazguemesidoia noninvasiveassessmentofanengineeredbioactivegraftinmyocardialinfarctionimpactoncardiacfunctionandscarhealing AT pratvidalcristina noninvasiveassessmentofanengineeredbioactivegraftinmyocardialinfarctionimpactoncardiacfunctionandscarhealing AT crisostomoveronica noninvasiveassessmentofanengineeredbioactivegraftinmyocardialinfarctionimpactoncardiacfunctionandscarhealing AT sanchezmargallofranciscom noninvasiveassessmentofanengineeredbioactivegraftinmyocardialinfarctionimpactoncardiacfunctionandscarhealing AT lluciavalldeperasaida noninvasiveassessmentofanengineeredbioactivegraftinmyocardialinfarctionimpactoncardiacfunctionandscarhealing AT bogonezfrancopaco noninvasiveassessmentofanengineeredbioactivegraftinmyocardialinfarctionimpactoncardiacfunctionandscarhealing AT pereagilisaac noninvasiveassessmentofanengineeredbioactivegraftinmyocardialinfarctionimpactoncardiacfunctionandscarhealing AT rourasantiago noninvasiveassessmentofanengineeredbioactivegraftinmyocardialinfarctionimpactoncardiacfunctionandscarhealing AT bayesgenisantoni noninvasiveassessmentofanengineeredbioactivegraftinmyocardialinfarctionimpactoncardiacfunctionandscarhealing |